双能CT预测胰腺导管腺癌的组织学分级与生存
回顾性纳入2017年1月至2023年3月间169例经病理证实、术前行第三代双源双能CT双期增强扫描的胰腺导管腺癌患者,随机分为训练组118例和验证组51例。血管侵犯、静脉期标准化碘浓度和静脉期有效原子序数为组织学分级的独立预测因子,构建的列线图在训练组和验证组预测高级别肿瘤的AUC分别为0.887和0.844,列线图预测的高级别胰腺导管腺癌与较差的总生存相关。
要点
- 静脉期标准化碘浓度和有效原子序数联合血管侵犯可无创预测胰腺导管腺癌组织学分级。
- 列线图预测高级别胰腺导管腺癌的训练组AUC为0.887,验证组AUC为0.844。
- 病理和列线图评分预测的高级别胰腺导管腺癌均与较差的总生存相关(均P<0.05)。
核心结论
- 结合双能CT参数与影像学特征的列线图可在术前预测胰腺导管腺癌的组织学分级和总生存。
研究设计与样本
- 回顾性收集2017年1月至2023年3月169例经病理证实、术前行第三代双源双能CT增强双期扫描的胰腺导管腺癌连续患者,随机分为训练组118例和验证组51例,由两名放射科医师评估3项临床和7项影像学特征并测量16项双能CT参数,采用单因素和多因素分析筛选独立预测因子并构建预测模型和列线图。
关键影像表现/征象
- 血管侵犯、静脉期标准化碘浓度和静脉期有效原子序数为组织学分级的独立预测因子。
- 训练组中43例(36.4%)、验证组中19例(37.3%)经病理证实为高级别胰腺导管腺癌。
诊断标准与关键数值
- 列线图预测高级别胰腺导管腺癌的AUC在训练组为0.887、验证组为0.844。
- 列线图在两个队列中校准良好,且比单一参数更有益。
- 病理和列线图评分预测的高级别胰腺导管腺癌均与较差的总生存相关(均P<0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: We evaluated the value of dual-energy computed tomography (DECT) parameters derived from pancreatic ductal adenocarcinoma (PDAC) to discriminate between high- and low-grade tumors and predict overall survival (OS) in patients.
METHODS: Data were retrospectively collected from 169 consecutive patients with pathologically confirmed PDAC who underwent third-generation dual-source DECT enhanced dual-phase scanning before surgery between January 2017 and March 2023. Patients with prior treatments, other malignancies, small tumors, or poor-quality scans were excluded. Two radiologists evaluated three clinical and seven radiological features and measured sixteen DECT-derived parameters. Univariate and multivariate analyses were applied to select independent predictors. A prediction model and a corresponding nomogram were developed, and the area under the curve (AUC), calibration, and clinical applicability were assessed. The correlations between factors and OS were evaluated using Kaplan-Meier survival and Cox regression analyses.
RESULTS: One hundred sixty-nine patients were randomly divided into training (n = 118) and validation (n = 51) cohorts, among which 43 (36.4%) and 19 (37.3%) had high-grade PDAC confirmed by pathology, respectively. The vascular invasion, normalized iodine concentration in the venous phase, and effective atomic number in the venous phase were independent predictors for histological grading. A nomogram was constructed to predict the risk of high-grade tumors in PDAC, with AUCs of 0.887 and 0.844 in the training and validation cohorts, respectively. The nomogram exhibited good calibration and was more beneficial than a single parameter in both cohorts. Pathological- and nomoscore-predicted high-grade PDACs were associated with poor OS (all p < 0.05).
CONCLUSIONS: The nomogram, which combines DECT parameters and radiological features, can predict the histological grade and OS in patients with PDAC before surgery.
KEY POINTS: Question Preoperative determination of histological grade in PDAC is crucial for guiding treatment, yet current methods are invasive and limited. Findings A DECT-based nomogram combining vascular invasion, normalized iodine concentration, and effective atomic number accurately predicts histological grade and OS in PDAC patients. Clinical relevance The DECT-based nomogram is a reliable, non-invasive tool for predicting histological grade and OS in PDAC. It provides essential information to guide personalized treatment strategies, potentially improving patient management and outcomes.
引用
- Chen W, Lin G, Li X, et al. Dual-energy computed tomography for predicting histological grading and survival in patients with pancreatic ductal adenocarcinoma. Eur Radiol. 2024. PMID: 39414655. doi:10.1007/s00330-024-11109-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。